| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.8M | -59.4% |
| Cost of Revenue | $3.0M | -52.5% |
| Gross Profit | -$220K | -140.5% |
| R&D Expense | $76K | +0.0% |
| SG&A Expense | $2.9M | -6.7% |
| Operating Income | -$3.2M | -7.4% |
| Pre-tax Income | -$3.1M | -8.1% |
| Net Income | -$3.1M | -8.1% |
| EPS (Basic) | -$4.22 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.5M | -24.4% |
| Accounts Receivable | $13K | -30.1% |
| Inventory | $26K | -91.2% |
| Current Assets | $10.1M | -24.4% |
| Total Assets | $10.4M | -24.8% |
| Current Liabilities | $1.0M | -17.7% |
| Total Liabilities | $1.2M | -23.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.1M | +50.1% |
| Investing Cash Flow | $200 | +0.0% |
| -1072.2% |
| EPS (Diluted) | -$4.22 | -1072.2% |
| Stockholders' Equity |
| $9.2M |
| -25.0% |